Associate Professor Doctor Hoo Fan Kee
Board of Advisor at Precision Diagnostics
MD (Mal), MRCP (UK), MRCPS (Glasgow)
Doctor Hoo Fan Kee is an Associate Professor in the Department of Medicine in the Faculty of Medicine and Health Sciences at Universiti Putra Malaysia (UPM). He is a Clinical Neurologist and Internal Medicine Specialist at Hospital Sultan Abdul Aziz Shah, UPM.
Dr. Hoo participates in several professional committees, including being the chairman of the Malaysia Stroke Council since 2018, a member of the Global Neuro Research Coalition, and a panelist of the Malaysia Clinical Practice Guidelines Panel for the Management of Ischemic Stroke from 2018 to 2020 and the Management of Patent Foramen Ovale-Stroke 2022.
Dr. Hoo has special interests in neurology, stroke, lifestyle diseases, and internal medicine. He was a principal investigator in clinical trials such as DRAGON, TRIDENT, and TICH-3. Dr. Hoo has been involved in over 100 publications in international journals.
Fan Kee Hoo is an Associate Professor in the Department of Medicine Faculty of Medicine and Health Sciences at Universiti Putra Malaysia. He specialized in Neurology. His clinical interests are Neurology, Stroke, Lifestyle Disease, Internal Medicine, Peripheral Nerves, and Spinal Cord.
Professional Qualifications
- Board of Advisor | Precision Diagnostics (PD)
- Committee Member of Industry, Community & Networking | Precision Medicine & Scientific Wellness (PMedS)
- Consultant Neurologist & Internal Medicine Physician | Beacon Hospital
- President | Malaysia Stroke Council
- Associate Professor (Medicine) | Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (UPM)
- Achieved as one of the Membership of the Royal College of Physicians (MRCP) in the UK
- Achieved the WSO Angels Award under the Malaysia Stroke Council
Publications
Theme choice in oral case presentations: Differences between medical novices and experts, Universiti Putra Malaysia Institutional Repository – 2021
NeuroAid II (MLC901) and polypharmacy in stroke and the risk of hepatotoxicity: a case report, Universiti Putra Malaysia Institutional Repository – 2021
Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: a case report, Universiti Putra Malaysia Institutional Repository – 2021
Coronavirus Disease-2019: Knowledge and Practices Behaviour of Healthcare Workers at a University Teaching Hospital in Malaysia, Universiti Putra Malaysia Institutional Repository – 2021
Effect of SGLT-2 Inhibitors on Non-alcoholic Fatty Liver Disease among Patients with Type 2 Diabetes Mellitus: Systematic Review with Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials, Universiti Putra Malaysia Institutional Repository – 2021
Organisations
- Malaysia Stroke Council, President
Featuring
PRECISE Pharmacogenomics
Using Genome-wide technology, we can determine how genetic information affects your body’s response to medication through our DNA Test Kit. Our report supports clinicians in providing Clinical Recommendations and Personalized Targeted Treatments. Find out more about Malaysia’s 1st Genome-wide Pharmacogenomic Report Accredited PRECISE Pharmacogenomics!
- Covers more than > 1,000+ genes
- 20+ Therapeutics Areas & 500+ Medications
- Clinical Accredited & Recommended
- Maximise & Optimise Medication Effectiveness